UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Current Treatment of Pulmonary Arterial Hypertension

Chest, 2006-10, Vol.130 (4), p.1198-1202

Rich, Stuart

2006

Volltextzugriff (PDF)

Prediction of Mortality in Pulmonary Embolism Based on Left Atrial Volume Measurements

Chest, 2016-07, Vol.150 (1), p.253-254

2016

Volltextzugriff (PDF)

Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty

Journal of the American College of Cardiology, 2017-04, Vol.69 (14), p.1795-1806

2017

Volltextzugriff (PDF)

The 6-Minute Walk Test as a Primary Endpoint in Clinical Trials for Pulmonary HypertensionEditorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

Journal of the American College of Cardiology, 2012-09, Vol.60 (13), p.1202

Rich, Stuart

2012

Volltextzugriff (PDF)

PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1951-A1951

2018

Volltextzugriff (PDF)

Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

Chest, 2014-08, Vol.146 (2), p.449-475

2014

Volltextzugriff (PDF)

Abstract 15294: 24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures and Increases Cardiac Output at Rest and Exercise in PH-HFpEF

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A15294-A15294

2020

Volltextzugriff (PDF)

Inaccuracy of Doppler Echocardiographic Estimates of Pulmonary Artery Pressures in Patients With Pulmonary Hypertension

Chest, 2011-05, Vol.139 (5), p.988-993

2011

Volltextzugriff (PDF)

The Transition From Chronic Intravenous To Oral Levosimendan Is Safe And Effective In Patients With Pulmonary Hypertension With Heart Failure And Preserved Ejection Fraction

Journal of cardiac failure, 2023-04, Vol.29 (4), p.714-715

2023

Volltextzugriff (PDF)

Venous Tone and Stressed Blood Volume in Heart Failure

Journal of the American College of Cardiology, 2022-05, Vol.79 (18), p.1858-1869

2022

Volltextzugriff (PDF)

Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't

Advances in pulmonary hypertension, 2017-01, Vol.15 (4), p.184-189

2017

Volltextzugriff (PDF)

The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension

Journal of cardiovascular magnetic resonance, 2011-02, Vol.13 (S1), p.O77-O77, Article O77

2011

Volltextzugriff (PDF)

What is pulmonary arterial hypertension?

Pulmonary circulation, 2012-07, Vol.2 (3), p.271-272

Rich, Stuart

2012

Volltextzugriff (PDF)

Targeting Pulmonary Vascular Disease To Improve Global Health

Chest, 2010-06, Vol.137 (6), p.1S-5S

2010

Volltextzugriff (PDF)

Levosimendan Improves Hemodynamics And Submaximal Exercise Capacity In Ph-hfpef: Primary Results From The Help-ph-hfpef Multicenter Randomized Controlled Trial

Journal of cardiac failure, 2020-12, Vol.26 (12), p.1108-1108

2020

Volltextzugriff (PDF)

ONE-YEAR CHANGES IN RIGHT VENTRICULAR STRAIN FOLLOWING PULMONARY THROMBOENDARTERECTOMY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.2102-2102

2020

Volltextzugriff (PDF)

Pulmonary Vascular Disease: The Global Perspective

Chest, 2010, Vol.137 (6)

2010

Volltextzugriff (PDF)

Pulmonary hypertension and late gadolinium enhancement of the right ventricular insertion point and its clinical implications

Journal of cardiovascular magnetic resonance, 2010-01, Vol.12 (S1), p.P261-P261, Article P261

2010

Volltextzugriff (PDF)

NIH Registry on Primary Pulmonary Hypertension: Baseline Characteristics of the Patients Enrolled

The Pulmonary Circulation, Normal and Abnormal, 2016, p.451-458

1125.65, 2016

Volltextzugriff (PDF)

PVRI PH-ARC Taskforce

PVRI review, 2011-07, Vol.3 (2), p.103

Rich, Stuart

2011

Volltextzugriff (PDF)

Peter Raymond, MBE

PVRI review, 2011-01, Vol.3 (1), p.4

Rich, Stuart

2011

Volltextzugriff (PDF)

30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR)

Journal of the American College of Cardiology, 2018-03, Vol.71 (11), p.A1004-A1004

2018

Volltextzugriff (PDF)

EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study

Pulmonary circulation, 2021-11, p.204589402110614

2021

Volltextzugriff (PDF)

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF

JACC. Heart failure, 2021-05, Vol.9 (5), p.360-370

2021

Volltextzugriff (PDF)

Issues facing the conduct of clinical trials in pulmonary hypertension on a global scale

PVRI review, 2009-04, Vol.1 (2), p.100

Rich, Stuart

2009

Volltextzugriff (PDF)

1 – 25 von 289

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(208)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(288)
Japanisch
(7)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Current Treatment of Pulmonary Arterial Hypertension

Prediction of Mortality in Pulmonary Embolism Based on Left Atrial Volume Measurements

Early Feasibility Study of a Transcatheter Tricuspid Valve Annuloplasty

The 6-Minute Walk Test as a Primary Endpoint in Clinical Trials for Pulmonary HypertensionEditorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology

PULMONARY VASOREACTIVITY TESTING WITH ADENOSINE PREDICTS LONG TERM HEMODYNAMIC RESPONSE TO PROSTACYCLIN MONOTHERAPY, AND PROSTACYCLIN AND PHOSPHODIESTERASE-5 INHIBITOR COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION

Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults

Abstract 15294: 24-hour Levosimendan Infusion Decreases Biventricular Filling Pressures and Increases Cardiac Output at Rest and Exercise in PH-HFpEF

Inaccuracy of Doppler Echocardiographic Estimates of Pulmonary Artery Pressures in Patients With Pulmonary Hypertension

The Transition From Chronic Intravenous To Oral Levosimendan Is Safe And Effective In Patients With Pulmonary Hypertension With Heart Failure And Preserved Ejection Fraction

Venous Tone and Stressed Blood Volume in Heart Failure

Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't

The role of late gadolinium enhancement of the right ventricular insertion point predicts survival in patients with pulmonary hypertension

What is pulmonary arterial hypertension?

Targeting Pulmonary Vascular Disease To Improve Global Health

Levosimendan Improves Hemodynamics And Submaximal Exercise Capacity In Ph-hfpef: Primary Results From The Help-ph-hfpef Multicenter Randomized Controlled Trial

ONE-YEAR CHANGES IN RIGHT VENTRICULAR STRAIN FOLLOWING PULMONARY THROMBOENDARTERECTOMY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Pulmonary Vascular Disease: The Global Perspective

Pulmonary hypertension and late gadolinium enhancement of the right ventricular insertion point and its clinical implications

NIH Registry on Primary Pulmonary Hypertension: Baseline Characteristics of the Patients Enrolled

PVRI PH-ARC Taskforce

Peter Raymond, MBE

30 DAY RESULTS OF THE SCOUT I STUDY IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION (TR)

EXPRESS: Prevalence, Incidence, and Survival of Pulmonary Arterial Hypertension: A Systematic Review for the Global Burden of Disease 2020 Study

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF

Issues facing the conduct of clinical trials in pulmonary hypertension on a global scale

Aktive Filter

Suchergebnisse filtern